Literature DB >> 12138198

RIP2, a checkpoint in myogenic differentiation.

Barbara Munz1, Eberhard Hildt, Matthew L Springer, Helen M Blau.   

Abstract

Using a subtractive cDNA library hybridization approach, we found that receptor interacting protein 2 (RIP2), a tumor necrosis factor receptor 1 (TNFR-1)-associated factor, is a novel early-acting gene that decreases markedly in expression during myogenic differentiation. RIP2 consists of three domains: an amino-terminal kinase domain, an intermediate domain, and a carboxy-terminal caspase activation and recruitment domain (CARD). In some cell types, RIP2 has been shown to be a potent inducer of apoptosis and an activator of NF-kappa B. To analyze the function of RIP2 during differentiation, we transduced C2C12 myoblasts with retroviral vectors to constitutively produce RIP2 at high levels. When cultured in growth medium, these cells did not show an enhanced rate of proliferation compared to controls. When switched to differentiation medium, however, they continued to proliferate, whereas control cells withdrew from the cell cycle, showed increased expression of differentiation markers such as myogenin, and began to differentiate into multinucleated myotubes. The complete RIP2 protein appeared to be necessary to inhibit myogenic differentiation, since two different deletion mutants lacking either the amino-terminal kinase domain or the carboxy-terminal CARD had no effect. A mutant deficient in kinase activity, however, had effects similar to wild-type RIP2, indicating that phosphorylation was not essential to the function of RIP2. Furthermore, RIP proteins appeared to be important during myogenic differentiation in vivo, as we detected a marked decrease in expression of the RIP2 homolog RIP in several muscle tissues of the dystrophic mdx mouse, a model for continuous muscle degeneration and regeneration. We conclude that RIP proteins can act independently of TNFR-1 stimulation by ligand to modulate downstream signaling pathways, such as activation of NF-kappa B. These results implicate RIP2 in a previously unrecognized role: a checkpoint for myogenic proliferation and differentiation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12138198      PMCID: PMC133983          DOI: 10.1128/MCB.22.16.5879-5886.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  35 in total

Review 1.  How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex.

Authors:  M Karin
Journal:  Oncogene       Date:  1999-11-22       Impact factor: 9.867

2.  ERK1/2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusion.

Authors:  N C Jones; Y V Fedorov; R S Rosenthal; B B Olwin
Journal:  J Cell Physiol       Date:  2001-01       Impact factor: 6.384

3.  Developmental progression of myosin gene expression in cultured muscle cells.

Authors:  L Silberstein; S G Webster; M Travis; H M Blau
Journal:  Cell       Date:  1986-09-26       Impact factor: 41.582

4.  Mouse receptor interacting protein 3 does not contain a caspase-recruiting or a death domain but induces apoptosis and activates NF-kappaB.

Authors:  N J Pazdernik; D B Donner; M G Goebl; M A Harrington
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

5.  Elevated p21 mRNA level in skeletal muscle of DMD patients and mdx mice indicates either an exhausted satellite cell pool or a higher p21 expression in dystrophin-deficient cells per se.

Authors:  S Endesfelder; A Krahn; K A Kreuzer; U Lass; C A Schmidt; C Jahrmarkt; A von Moers; A Speer
Journal:  J Mol Med (Berl)       Date:  2000       Impact factor: 4.599

6.  The RIP-like kinase, RIP3, induces apoptosis and NF-kappaB nuclear translocation and localizes to mitochondria.

Authors:  G M Kasof; J C Prosser; D Liu; M V Lorenzi; B C Gomes
Journal:  FEBS Lett       Date:  2000-05-19       Impact factor: 4.124

7.  NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia.

Authors:  D C Guttridge; M W Mayo; L V Madrid; C Y Wang; A S Baldwin
Journal:  Science       Date:  2000-09-29       Impact factor: 47.728

8.  Activated Raf inhibits myogenesis through a mechanism independent of activator protein 1-mediated myoblast transformation.

Authors:  C M Dorman; S E Johnson
Journal:  J Biol Chem       Date:  2000-09-01       Impact factor: 5.157

9.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

10.  Activated raf kinase inhibits muscle cell differentiation through a MEF2-dependent mechanism.

Authors:  B Winter; H H Arnold
Journal:  J Cell Sci       Date:  2000-12       Impact factor: 5.285

View more
  13 in total

1.  NF-κB negatively impacts the myogenic potential of muscle-derived stem cells.

Authors:  Aiping Lu; Jonathan D Proto; Lulin Guo; Ying Tang; Mitra Lavasani; Jeremy S Tilstra; Laura J Niedernhofer; Bing Wang; Denis C Guttridge; Paul D Robbins; Johnny Huard
Journal:  Mol Ther       Date:  2011-12-13       Impact factor: 11.454

2.  Nerve growth factor induces cell cycle arrest of astrocytes.

Authors:  Andrea B Cragnolini; Marta Volosin; Yangyang Huang; Wilma J Friedman
Journal:  Dev Neurobiol       Date:  2012-06       Impact factor: 3.964

3.  Pro-angiogenic activity of TLRs and NLRs: a novel link between gut microbiota and intestinal angiogenesis.

Authors:  Anja Schirbel; Sean Kessler; Florian Rieder; Gail West; Nancy Rebert; Kewal Asosingh; Christine McDonald; Claudio Fiocchi
Journal:  Gastroenterology       Date:  2012-11-10       Impact factor: 22.682

4.  Integrative Bayesian Analysis Identifies Rhabdomyosarcoma Disease Genes.

Authors:  Lin Xu; Yanbin Zheng; Jing Liu; Dinesh Rakheja; Sydney Singleterry; Theodore W Laetsch; Jack F Shern; Javed Khan; Timothy J Triche; Douglas S Hawkins; James F Amatruda; Stephen X Skapek
Journal:  Cell Rep       Date:  2018-07-03       Impact factor: 9.423

5.  NF-kappaB regulation of YY1 inhibits skeletal myogenesis through transcriptional silencing of myofibrillar genes.

Authors:  Huating Wang; Erin Hertlein; Nadine Bakkar; Hao Sun; Swarnali Acharyya; Jingxin Wang; Micheal Carathers; Ramana Davuluri; Denis C Guttridge
Journal:  Mol Cell Biol       Date:  2007-04-16       Impact factor: 4.272

6.  Prolyl hydroxylase EGLN3 regulates skeletal myoblast differentiation through an NF-kappaB-dependent pathway.

Authors:  Jian Fu; Mark B Taubman
Journal:  J Biol Chem       Date:  2010-01-10       Impact factor: 5.157

7.  p204 protein overcomes the inhibition of core binding factor alpha-1-mediated osteogenic differentiation by Id helix-loop-helix proteins.

Authors:  Yi Luan; Xiu-Ping Yu; Ning Yang; Sally Frenkel; Lin Chen; Chuan-Ju Liu
Journal:  Mol Biol Cell       Date:  2008-02-20       Impact factor: 4.138

8.  Overexpression of the skNAC gene in human rhabdomyosarcoma cells enhances their differentiation potential and inhibits tumor cell growth and spreading.

Authors:  Janine Berkholz; Weronika Kuzyniak; Michael Hoepfner; Barbara Munz
Journal:  Clin Exp Metastasis       Date:  2014-09-11       Impact factor: 5.150

9.  Beta-catenin interacts with MyoD and regulates its transcription activity.

Authors:  Chang-Hoon Kim; Hannah Neiswender; Eun Joo Baik; Wen C Xiong; Lin Mei
Journal:  Mol Cell Biol       Date:  2008-03-03       Impact factor: 4.272

10.  IKK/NF-kappaB regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis.

Authors:  Nadine Bakkar; Jingxin Wang; Katherine J Ladner; Huating Wang; Jason M Dahlman; Micheal Carathers; Swarnali Acharyya; Michael A Rudnicki; Andrew D Hollenbach; Denis C Guttridge
Journal:  J Cell Biol       Date:  2008-02-25       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.